Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bioequivalence Study Of Diltiazem In 60 Mg Tablets As Tilazem 60 Made By Pfizer, S.A. DE C.V., Versus Angiotrofin 60 Mg Made By Amstrong Laboratorios De Mexico, S.A. DE C.V. Study In 26 Healthy Volunteers Of Both Genders Under Fasting Conditions.

Next Previous
Trial Profile

Bioequivalence Study Of Diltiazem In 60 Mg Tablets As Tilazem 60 Made By Pfizer, S.A. DE C.V., Versus Angiotrofin 60 Mg Made By Amstrong Laboratorios De Mexico, S.A. DE C.V. Study In 26 Healthy Volunteers Of Both Genders Under Fasting Conditions.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Diltiazem (Primary)
  • Indications Angina pectoris; Hypertension
  • Focus Pharmacokinetics

Most Recent Events

  • 12 Sep 2011 Biomarkers information updated
  • 19 Aug 2011 Primary endpoints added as reported by ClinicalTrials.gov.
  • 14 Jul 2010 Actual number of patients added to 26 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top